Browsing publications by Professor Deborah Tweddle

Newcastle AuthorsTitleYearFull text
Professor Deborah Tweddle
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma2016
Dr Gareth Veal
Julie Errington
Dr James Hayden
Professor Deborah Tweddle
Carboplatin therapeutic monitoring in preterm and full-term neonates2015
Dr Nicholas Bown
Professor John Lunec
Professor Deborah Tweddle
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification2015
Dr Lindi Chen
Professor Herbie Newell
Professor John Lunec
Professor Deborah Tweddle
Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma2015
Laura Evans
Dr Lindi Chen
Dr Elaine Willmore
Professor Herbie Newell
Professor Deborah Tweddle
et al.
SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastoma2015
Andrew Shouksmith
Laura Evans
Professor Deborah Tweddle
Duncan Miller
Dr Elaine Willmore
et al.
Synthesis and Activity of Putative Small-​Molecule Inhibitors of the F-​Box Protein SKP22015
Dr Colin Muirhead
Professor Deborah Tweddle
Nermine Basta
Dr Richard McNally
Temporal clustering of neuroblastic tumours in children and young adults from Northern England2015
Dr Gareth Veal
Professor Jeff Errington
Professor Deborah Tweddle
Therapeutic drug monitoring approaches to the treatment of preterm and full-term neonates with cancer A UK experience2015
Professor Deborah Tweddle
Adherence to UK Children's Cancer and Leukaemia Group Guidelines for the Management of Low and Intermediate Risk Neuroblastoma, 2011-20132014
Nermine Basta
Richard Feltbower
Dr Peter James
Professor Deborah Tweddle
Dr Richard McNally
et al.
Characteristics of UK patients with relapsed, intermediate risk unresectable, non-MYCN amplified neuroblastoma: a pilot study2014
123456